# Biological Therapeutics Bioassay Subject Matter Expert Consulting Services to Support the Development of Therapeutic Biotechnology Products (Biologics)

> **NIH NIH N01** · — · 2024 · $9,900

## Abstract

The NINDS has a need for biological therapeutics assay development subject matter expert
(SME) consultants to provide technical recommendations and advice that will support the
translational development of novel therapeutics (Biologics) for NIH drug discovery and
development programs. The support included in this contract will cover bioassay development
and/or qualification/validation for a variety of biologics including but not limited to: monoclonal
antibodies, peptide therapeutics, viral vector therapeutics (e.g., AAV, lentiviruses, etc.), nucleic
acid and cell-based therapeutics, proteins, or other biological therapeutic modalities. Preferably,
consultants should have significant expertise supporting assay development for more than one
biological therapeutic modality (e.g., monoclonals, peptides, ASOs and viral vectors).

## Key facts

- **NIH application ID:** 11211319
- **Project number:** 75N95024P00068-0-0-1
- **Recipient organization:** —
- **Principal Investigator:** —
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $9,900
- **Award type:** —
- **Project period:** 2024-01-03 → 2025-01-02

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11211319

## Citation

> US National Institutes of Health, RePORTER application 11211319, Biological Therapeutics Bioassay Subject Matter Expert Consulting Services to Support the Development of Therapeutic Biotechnology Products (Biologics) (75N95024P00068-0-0-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11211319. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*